The Prevalence of Multiple Drug Resistance Escherichia Coli and Klebsiella Pneumoniae Isolated from Patients with Urinary Tract Infections

Overview

Journal J Clin Lab Anal

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
Pathology

Date 2022 Jul 23

PMID 35870190

Authors

Mays B Jalil

Mohammed Younus Naji Al Atbee

Affiliations

Soon will be listed here.

Abstract

Background: Urinary tract infections (UTIs) and bacterial resistance to antibiotics is global health problem and a threat to public health in many countries.

Aims: The study aimed to determine the prevalence of MDR Escherichia coli and Klebsiella pneumoniae in UTI patients.

Materials & Methods: The midstream urine samples of 120 patients were collected and cultured as described by the protocols at the respective sample collection sites on MacConkey Blood agar. Samples were tested by using the fully automated VITEK 2 Compact system for Gram-negative identification and detection of antimicrobial susceptibility of microorganisms.

Results: The most prevalent pathogen was E. coli, which was found in 82 (68.3%) urine samples, followed by K. pneumonia, found in 38 (31.7%) urine samples. As far as antibiotic resistance is concerned, E. coli isolates were found to be highly resistant for ceftriaxone (89.0% of the isolates), ampicillin (86.6%), levofloxacin (82.9%), cefotaxime (79.3%), aztreonam (74.4%), ceftazidime (68.3%) and gentamicin, piperacillin, and trimethoprim-sulfamethoxazole, 54.9 and 53.7%, respectively. The E. coli isolates were found to be relatively less resistant to imipenem (2.4%), cefepime (34.1%), and ciprofloxacin (35.4%). For K. pneumonia isolates, high resistance rates were observed for piperacillin (81.6%), levofloxacin (78.9%), ampicillin (76.3%), cefotaxime (73.7%), trimethoprim-sulfamethoxazole (71.1%), ceftazidime (65.8%), gentamicin (63.2%), cefepime (50.0%), and aztreonam (44.7%). However, moderate resistance rates were detected for these were found to be less resistant for imipenem (13.2%), ceftriaxone (31.6%), and ciprofloxacin (36.8%).

Conclusion: E. coli and K. pneumoniae from the clinical isolates displayed high resistance to many antibiotics in UTI patients.

Citing Articles

Cranberry-derived bioactives for the prevention and treatment of urinary tract infections: antimicrobial mechanisms and global research trends in nutraceutical applications.

Jangid H, Shidiki A, Kumar G Front Nutr. 2025; 12:1502720.

PMID: 40078413 PMC: 11896822. DOI: 10.3389/fnut.2025.1502720.

Urinary Tract Infections Caused by and Prolonged Treatment with Trimethoprim/Sulfamethoxazole.

Filev R, Lyubomirova M, Bogov B, Kolevski A, Pencheva V, Kalinov K Microorganisms. 2025; 13(2).

PMID: 40005786 PMC: 11858204. DOI: 10.3390/microorganisms13020422.

Targeting beta-lactamase activity with Oxacyclohexadecan-2-one in carbapenem-resistant uropathogenic E. coli: A molecular simulation approach.

Balaji P, N M, Bhaskar M E, R G, Paul S, R M PLoS One. 2025; 20(2):e0317941.

PMID: 39964973 PMC: 11835335. DOI: 10.1371/journal.pone.0317941.

Prevalence of carbapenem-resistant (CRE) in Saudi Arabia: A systematic review and meta-analysis.

Alshehri A, Irekeola A Saudi Pharm J. 2024; 32(11):102186.

PMID: 39498344 PMC: 11532984. DOI: 10.1016/j.jsps.2024.102186.

Trends in Antimicrobial Resistance of Uropathogens Isolated from Urinary Tract Infections in a Tertiary Care Hospital in Dhaka, Bangladesh.

Chowdhury S, Tahsin P, Xu Y, Mosaddek A, Muhamadali H, Goodacre R Antibiotics (Basel). 2024; 13(10).

PMID: 39452192 PMC: 11505449. DOI: 10.3390/antibiotics13100925.

References

Jalil M, Al Atbee M . The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections. J Clin Lab Anal. 2022; 36(9):e24619. PMC: 9459318. DOI: 10.1002/jcla.24619. View

Bischoff S, Walter T, Gerigk M, Ebert M, Vogelmann R . Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department. BMC Infect Dis. 2018; 18(1):56. PMC: 5787273. DOI: 10.1186/s12879-018-2960-9. View

Flores-Mireles A, Walker J, Caparon M, Hultgren S . Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015; 13(5):269-84. PMC: 4457377. DOI: 10.1038/nrmicro3432. View

Alanazi M, Alqahtani F, Aleanizy F . An evaluation of E. coli in urinary tract infection in emergency department at KAMC in Riyadh, Saudi Arabia: retrospective study. Ann Clin Microbiol Antimicrob. 2018; 17(1):3. PMC: 5806437. DOI: 10.1186/s12941-018-0255-z. View

Bean D, Krahe D, Wareham D . Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract isolates, London 2005-2006. Ann Clin Microbiol Antimicrob. 2008; 7:13. PMC: 2440378. DOI: 10.1186/1476-0711-7-13. View

Cohen-Nahum K, Saidel-Odes L, Riesenberg K, Schlaeffer F, Borer A . Urinary tract infections caused by multi-drug resistant Proteus mirabilis: Risk factors and clinical outcomes. Infection. 2009; 38(1):41-6. DOI: 10.1007/s15010-009-8460-5. View

Gupta K, Hooton T, Naber K, Wullt B, Colgan R, Miller L . International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011; 52(5):e103-20. DOI: 10.1093/cid/ciq257. View

Arana D, Rubio M, Alos J . Evolution of antibiotic multiresistance in Escherichia coli and Klebsiella pneumoniae isolates from urinary tract infections: A 12-year analysis (2003-2014). Enferm Infecc Microbiol Clin. 2016; 35(5):293-298. DOI: 10.1016/j.eimc.2016.02.018. View

Magliano E, Grazioli V, Deflorio L, Leuci A, Mattina R, Romano P . Gender and age-dependent etiology of community-acquired urinary tract infections. ScientificWorldJournal. 2012; 2012:349597. PMC: 3351074. DOI: 10.1100/2012/349597. View

10.

Nitzan O, Elias M, Chazan B, Saliba W . Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndr Obes. 2015; 8:129-36. PMC: 4346284. DOI: 10.2147/DMSO.S51792. View

11.

Foxman B . The epidemiology of urinary tract infection. Nat Rev Urol. 2010; 7(12):653-60. DOI: 10.1038/nrurol.2010.190. View

12.

Jaggi N, Sissodia P, Sharma L . Control of multidrug resistant bacteria in a tertiary care hospital in India. Antimicrob Resist Infect Control. 2012; 1(1):23. PMC: 3524029. DOI: 10.1186/2047-2994-1-23. View

13.

Livermore D, Pearson A . Antibiotic resistance: location, location, location. Clin Microbiol Infect. 2007; 13 Suppl 2:7-16. DOI: 10.1111/j.1469-0691.2007.01724.x. View

14.

Padmini N, Ajilda A, Sivakumar N, Selvakumar G . Extended spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae: critical tools for antibiotic resistance pattern. J Basic Microbiol. 2017; 57(6):460-470. DOI: 10.1002/jobm.201700008. View

15.

Saemann M, Horl W . Urinary tract infection in renal transplant recipients. Eur J Clin Invest. 2008; 38 Suppl 2:58-65. DOI: 10.1111/j.1365-2362.2008.02014.x. View

16.

Leski T, Taitt C, Bangura U, Stockelman M, Ansumana R, Cooper 3rd W . High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone. BMC Infect Dis. 2016; 16:167. PMC: 4836052. DOI: 10.1186/s12879-016-1495-1. View

17.

Micali S, Isgro G, Bianchi G, Miceli N, Calapai G, Navarra M . Cranberry and recurrent cystitis: more than marketing?. Crit Rev Food Sci Nutr. 2014; 54(8):1063-75. DOI: 10.1080/10408398.2011.625574. View

18.

Gad G, El-Domany R, Zaki S, Ashour H . Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. J Antimicrob Chemother. 2007; 60(5):1010-7. DOI: 10.1093/jac/dkm348. View

19.

Spellberg B, Bartlett J, Gilbert D . The future of antibiotics and resistance. N Engl J Med. 2013; 368(4):299-302. PMC: 3617123. DOI: 10.1056/NEJMp1215093. View

20.

Khawcharoenporn T, Vasoo S, Singh K . Urinary Tract Infections due to Multidrug-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Chicago Emergency Department. Emerg Med Int. 2013; 2013:258517. PMC: 3844142. DOI: 10.1155/2013/258517. View